Vividion Therapeutics
Agent42Agent Readiness: 42/100. Above median. Measured by StartupHub.ai. Median 41.Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.
About
Vividion Therapeutics is a biopharmaceutical company that utilizes novel discovery technologies to unlock high-value, traditionally undruggable targets with precision therapeutics for devastating cancers and immune disorders. Their platform combines chemoproteomics and covalent chemistry to identify and develop small molecule drugs for diseases with unmet medical needs. Vividion operates as a wholly owned, independently operated subsidiary of Bayer AG.
Key facts
At-a-glance profile data
- Website
- vividion.com
- Headquarters
- San Diego, United States
- Founded
- 2017
- Employees
- 265
- Total funding
- $267M (Series C)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 24 Feb 2021 | Series C | $135M | Logos Capital |
| 30 Apr 2019 | Series B | $82M | Nextech Invest |
| 2 Feb 2017 | Series A | $50M | Arch Venture Partners |
Tech stack
Detected on vividion.com, last scanned 20 Sept 2026. Run your own scan
- Frontend
- jQuery, Bootstrap
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- Hosting
- Google Cloud
- Email provider
- Microsoft 365
Frequently asked
How much funding has Vividion Therapeutics raised?
Vividion Therapeutics has raised a total of $267M in funding. The most recent round on record is Series C.
How many employees does Vividion Therapeutics have?
Vividion Therapeutics has approximately 265 people on record.